Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis
The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To estimate the effect of combined heparin and aspirin compared with aspirin monotherapy in pregnant women with antiphospholipid syndrome and recurrent pregnancy loss. DATA SOURCES: We searched the PubMed database up to December 2009 for English-language studies using the key words "aspirin AND (heparin OR low molecular weight heparin), (antiphospholipid OR anticardiolipin OR aPL) AND pregnancy." METHODS OF STUDY SELECTION: Two hundred ninety- two studies were initially screened. Randomized controlled trials comparing the effect of heparin (unfractionated heparin or low molecular weight heparin) plus aspirin compared with aspirin alone on the live-birth rate in women with a history of at least two miscarriages and antiphospholipid antibodies were eligible. TABULATION, INTEGRATION, AND RESULTS: The pooled effect of unfractionated heparin and low molecular weight heparin was evaluable in three and two randomized controlled studies, respectively, with regard to live births, which was the major outcome. Overall, treatment effects were in favor of heparin against first-trimester losses (odd ratio [OR] 0.39, 95% confidence interval [CI] 0.24-0.65, number needed to treat 6). More specifically, unfractionated heparin displayed a significant effect (OR 0.26, 95% CI 0.14-0.48, number needed to treat 4), while the pooled effect of low molecular weight heparin was insignificant (OR 0.70, 95% CI 0.34-1.45). Combination therapy of either unfractionated heparin or low molecular weight heparin with aspirin failed to display any significant effect in the prevention of late-pregnancy losses. No significant differences were observed between treatment and control groups for any other outcomes. CONCLUSION: The combination of unfractionated heparin and aspirin confers a significant benefit in live births. However, the efficacy of low molecular weight heparin plus aspirin remains unproven, highlighting the urgent need for large controlled trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two further meta-analyses showed similar reduction in recurrent miscarriage for the aspirin and UFH group (OR 0.26, 95% CI 0.14-0.48).164”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [164]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
D'Cruz, D. P., Khamashta, M. A., & Hughes, G. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60279-7 · Cited by 992
Kutteh, W. H. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70610-5 · Cited by 803
Greer, I. A., & Nelson-Piercy, C. (2005) · Blood · doi:10.1182/blood-2005-02-0626 · Cited by 797
Estimation of a Common Effect Parameter from Sparse Follow-Up Data
Greenland, S., & Robins, J. M. (1985) · Biometrics · doi:10.2307/2530643 · Cited by 794
Cited by
Items 101–184 of 184
Recurrent Early Pregnancy Loss
Brezina, P. R., & Kutteh, W. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-52210-4_15 · Cited by 8
Levine, A. B., & Lockshin, M. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0673-4_6 · Cited by 8
Antiphospholipid syndrome: Unusual clinical presentations
Greaves, M. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70013-5 · Cited by 7
Evaluation and Management of Recurrent Pregnancy Loss
Rambaldi, M. P., Mecacci, F., & Paidas, M. J. (2011) · Placenta · doi:10.1016/j.placenta.2011.07.019 · Cited by 7
Sotiriadis, A. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15921 · Cited by 6
Ni, L., Sun, X., Zhao, D.-X., & Zhu, Z.-W. (2019) · Medicine · doi:10.1097/md.0000000000014619 · Cited by 6
Relationship of lupus nephritis and pregnancy: A narrative review
Elahi, T., Ahmed, S., & Mubarak, M. (2024) · World Journal of Nephrology · doi:10.5527/wjn.v13.i4.99700 · Cited by 5
Pertes de grossesse à répétition : étiologies et bilan, le point de vue du gynécologue-obstétricien
Toupet, A., Théau, A., Goffinet, F., & Tsatsaris, V. (2014) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2014.07.004 · Cited by 9
Consequences of antiphospholipid syndrome in pregnancy - A review
Gashi, A. M. (2023) · Romanian Journal of Rheumatology · doi:10.37897/rjr.2023.2.4 · Cited by 5
The role of aspirin in women’s health
Phillips, S., & Bolte, A. C. (2011) · International Journal of Women s Health · doi:10.2147/ijwh.s18033 · Cited by 5
Recurrent early pregnancy loss
Kutteh, W. H., Donnellan, N. M., Jaslow, C. R., & Stephenson, M. D. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.061 · Cited by 5
Youssef, A., Lashley, E. E. L. O., Vermeulen, N., & van der Hoorn, M. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05869-y · Cited by 5
Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss
Clark, C. A., Spitzer, K. A., Laskin, C. A., Crowther, M. R., & Ginsberg, J. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181f4e012 · Cited by 5
Therapy for antiphospholipid miscarriages: Throwing the baby out with the bathwater?
Chighizola, C. B., Shoenfeld, Y., & Meroni, P. L. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12792 · Cited by 4
Treatment of Systemic Lupus Erythematosus
Bertsias, G. K., Fanouriakis, A., & Boumpas, D. T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00081-4 · Cited by 4
Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Ortells, L. C., et al. (2019) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2018.11.013 · Cited by 5
Treatment of Systemic Lupus Erythematosus
Bertsias, G. K., Fanouriakis, A., & Boumpas, D. T. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00081-5 · Cited by 6
RESULTADOS OBSTÉTRICOS EN GESTANTES DIAGNOSTICADAS DE SÍNDROME ANTIFOSFOLÍPIDO
Félix, C., Badillo, M. P. C., Añón, I., Malde, F. J., Cáliz, R., & Puertas, A. (2021) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2020.05.005 · Cited by 4
Pregnancy and Rheumatic Diseases
Sammaritano, L. R., & Bermas, B. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00039-5 · Cited by 3
Recurrent Early Pregnancy Loss
Brezina, P. R., & Kutteh, W. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6837-0_13 · Cited by 3
Stratta, P., Canavese, C., Cena, T., Quaglia, M., Pergolini, P., Bellomo, G., & Magnani, C. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04436.x · Cited by 3
Laddad, M. M., Kshirsagar, N. S., Patil, S., Shinde, G. R., & Nimbalkar, P. (2014) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2014/2660 · Cited by 2
Is thrombin a “toxin” in the pathogenesis of preeclampsia?
Sugimura, M. (2015) · Hypertension Research in Pregnancy · doi:10.14390/jsshp.3.13 · Cited by 2
Inherited and Acquired Thrombophilia in Obstetrics
Paidas, M. J., Han, C. S., Hossain, N., & Lockwood, C. J. (2011) · Wiley-Blackwell eBooks · doi:10.1002/9781444328332.ch5 · Cited by 3
Burlá, M., Braga, A., Coulamy, L. B., de Oliveira, T. S., da Silva, E. P., & Vasques, F. P. (2015) · Revista Hospital Universitário Pedro Ernesto · doi:10.12957/rhupe.2015.18351 · Cited by 5
Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss
Ziakas, P. D., & Voulgarelis, M. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181f4e57e · Cited by 2
Self-citationReproductive and Hormonal Issues in Women with Autoimmune Diseases
Chakravarty, E. F. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00038-8 · Cited by 2
Eventos tromboembólicos y el embarazo: actualización en anticoagulación en mujeres embarazadas
Solís, A. E. C., Zamora, A. M. M., & Martín‐Zamora, A. C. (2019) · Revista Medica Sinergia · doi:10.31434/rms.v4i5.210 · Cited by 2
Anti-Phospholipid Antibodies and Pregnancy
Suryanarayan, D., & Garcia, D. A. (2014) · The Hematologist · doi:10.1182/hem.v11.4.2989 · Cited by 3
Síndrome antifosfolipídico obstétrico
(2021) · Revista Uruguaya de Medicina Interna · doi:10.26445/06.02.5 · Cited by 2
Berghella, M., & Achenbach, A. E. (2012) · Series in maternal-fetal medicine · doi:10.3109/9781841848259.015 · Cited by 2
Clinical recommendations on diagnostics and treatment of lupus nephritis (draft project)
Zakharova, E., Kozlovskaya, N. L., Korotchaeva, Y. V., Bobkova, I. N., Dobronravov, V., & Karunnaya, A. V. (2024) · Nephrology and Dialysis · doi:10.28996/2618-9801-2024-2suppl-70-113 · Cited by 3
Outcomes of IVF treatments in women with antiphospholipid antibodies or antiphospholipid syndrome
Shalamov, M. M., Kaufman, L., Simchen, M. J., Agmon‐Levin, N., Misgav, M., Orvieto, R., & Machtinger, R. (2024) · Thrombosis Research · doi:10.1016/j.thromres.2024.109144 · Cited by 1
Misra, D., & Aledort, L. M. (2010) · American Journal of Hematology · doi:10.1002/ajh.21909 · Cited by 1
The Pathogenic Mechanisms for Antiphospholipid Antibodies (aPL)-Mediated Pregnancy Loss
Simone, N. D., & D’Ippolito, S. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_4 · Cited by 1
“suffer from miscarriages and adverse pregnancy events [ 53 , 54 ].”
BackgroundAutoimmune Diseases: Rheumatic Diseases
Goetsch, A. L., Kimelman, D., & Woodruff, T. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-52316-3_8 · Cited by 1
Störung der Frühschwangerschaft und Aborte
von Steinburg, S. P., Schleußner, E., Kuon, R., Vomstein, K., & Tóth, B. (2018) · Springer eBooks · doi:10.1007/978-3-662-55622-1_10 · Cited by 1
Airoldi, J. A. (2011) · Series in maternal-fetal medicine · doi:10.3109/9781841848235.026 · Cited by 1
Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Ortells, L. C., et al. (2019) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2018.11.012 · Cited by 6
Wei, Y., Cai, S., Ding, J., Zeng, Y., Yin, T., & Diao, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90805-4.00021-3 · Cited by 1
Disorders of Early Pregnancy and Pregnancy Loss
von Steinburg, S. P., Schleußner, E., Kuon, R., Vomstein, K., & Tóth, B. (2023) · Springer eBooks · doi:10.1007/978-3-662-66256-4_10 · Cited by 2
The evaluation and management of recurrent pregnancy loss
Bedaiwy, M. A., Elbasueny, B., Iews, M., Rowe, T., & Jiang, I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85687-4.00017-8 · Cited by 1
Pregnancy and Disorders of the Nervous System
Aminoff, M. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407710-2.00031-x · Cited by 1
Rothschild, B. M. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.190358 · Cited by 1
(2010) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328340e116 · Cited by 1
Antiphospholipid Antibody Syndrome
DeLoughery, T. G. (2014) · Springer eBooks · doi:10.1007/978-3-319-09312-3_19 · Cited by 1
Infertility and reproductive endocrinology
Bieber, E. J., Sanfilippo, J. S., Horowitz, I., & Shafi, M. I. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.058 · Cited by 1
Martínez, H. A. S., García, E. A. L., & Mojica, C. H. B. (2011) · Medunab · doi:10.29375/01237047.1532
Does testicular sperm improve ICSI outcome in patients with necrozoospermia?
Negri, L., Benaglia, R., Smeraldi, A., Menduni, F., & Levi-Setti, P. E. (2011) · Placenta · doi:10.1016/j.placenta.2011.07.018
Lepercq, J. A. (2011) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(11)70789-4
The Antiphospholipid Syndrome Pregnancy
Cacciola, R. R., Cacciola, E. G., & Cacciola, E. (2015) · International Journal of Hematology Research
Síndrome antifosfolípido en mujeres con pérdidas recurrentes de embarazo: diagnóstico de laboratorio
Rodríguez-Pérez, L., González, D. C., Cabrera-Payne, Y., & González, M. T. (2015) · Revista cubana de hematología, inmunología y hemoterapia · Cited by 4
Lannon, B. M., & Zimon, A. E. (2011) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9781841848181.014
The Impact of aPL Detection on Pregnancy
Bertero, M. T., Kuzenko, A., & Bazzan, M. (2016) · Rare diseases of the immune system · doi:10.1007/978-3-319-24535-5_13
Identifying and managing lupus nephritis during pregnancy
Fredi, M., Gregorini, G. A., Zatti, S., Lojacono, A., & Tincani, A. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1228452
“trolled trials and systematic review of the literature support, the combined treatment with low-dose aspirin (LDA) and LMWH is most effective in preventing fetal loss [103,104].”
BackgroundTreatment of Pregnancy Complications in Antiphospholipid Syndrome
Nassar, A. H., Uthman, I. W., Eid, J., & Khamashta, M. A. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00018-1
Antiphospholipid Antibodies and Reproduction
Sammaritano, L. R. (2017) · Cambridge University Press eBooks · doi:10.1017/9781139976787.012
McNamee, K. M., & Farquharson, R. G. (2017) · Cambridge University Press eBooks · doi:10.1017/9781139976787.033
Evidence-Based Management of Recurrent Pregnancy Loss
Seckin, S. I., & Schlaff, W. D. (2016) · Topics in Obstetrics & Gynecology · doi:10.1097/01.pgo.0000481325.01286.8d
Therapeutische Konzepte bei habitueller Abortneigung: Viel hilft viel?
Vomstein, K., Feil, K., Kuon, R., & Tóth, B. (2018) · Der Gynäkologe · doi:10.1007/s00129-018-4226-4
Hematologic Disease in Implantation Failure
Neal, S. A., Franasiak, J. M., & Scott, R. T. (2017) · Springer eBooks · doi:10.1007/978-3-319-71967-2_8
Evidence Based Management in Recurrent Pregnancy Loss
Rashmi, R. (2017) · Springer eBooks · doi:10.1007/978-981-10-7338-0_15
Infektiologische und immunologische Aspekte bei Kinderwunsch
Kuon, R., Daniel, V., Vomstein, K., Weber, M., Gaiser, T., & Tóth, B. (2018) · Gynäkologische Endokrinologie · doi:10.1007/s10304-018-0196-9
The management of thromboembolic disease in pregnancy and puerperium
Bohîlțea, R. E., Ţurcan, N., & Cîrstoiu, M. M. (2019) · Obstetrica şi Ginecologia · doi:10.26416/obsgin.67.1.2019.2297
Rothschild, B. M. (2019) · Arthritis Care & Research · doi:10.1002/acr.24079
Rothschild, B. M. (2020) · Arthritis Care & Research · doi:10.1002/acr.24162
Medically Assisted Reproduction and Autoimmunity
Torres-Shafer, K., & Gagneux, P. (2020) · Springer eBooks · doi:10.1007/978-981-15-2377-9_32
Recurrent Miscarriage (Content last reviewed: 15th March 2020)
Malick, S. M., & Ganapathy, R. (2017)
Recurrent Pregnancy Loss in the First and Second Trimesters
Tarlatzis, B. C., Sotiriadis, A., & Grimbizis, G. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108582322.014
Inherited and Acquired Thrombophilias
Paidas, M. J. (2012) · Wiley eBooks · doi:10.1002/9781119963783.ch15
Vomstein, K. (2020) · Springer eBooks · doi:10.1007/978-3-662-59809-2_6
(2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328346809c
Facchinetti, F., & Monari, F. (2011) · Wiley eBooks · doi:10.1002/9781444398038.ch9
Sibai, B. M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.02.078
Antiphospholipid Antibody Syndrome
Sharma, A., & Khoiwal, K. (2017) · Springer eBooks · doi:10.1007/978-981-10-7338-0_8
Venkatesh, Y. S., Subbaiah, M., Kavadichanda, C. G., & Murugesan, R. (2024) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-024-01643-z
“Similarly, secondary APS has been shown to be associated with higher thrombotic events and pregnancy loss [16].”
The Role of Immunotherapy in the Treatment of Recurrent Miscarriage
Panah, S. R., & Mohammadi, H. (2023) · ملیون. · doi:10.61186/sjrm.8.1.43
Investigation and Management of Recurrent Pregnancy Loss: A Comprehensive Review of Guidelines
Giouleka, S., Tsakiridis, I. G., Arsenaki, E., Kalogiannidis, I. A., Mamopoulos, A. M., Papanikolaou, E. G. E., Athanasiadis, A. P., & Dagklis, T. (2024) · Topics in Obstetrics & Gynecology · doi:10.1097/01.pgo.0001026740.91850.b7
Antiphospholipid Antibody Syndrome
Verma, A. K., & Rani, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-4876-4_16
Ramzan, K., Dar, A., Nisar, I., Ramzan, A., dar, B. M. U. D., & Khan, A. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13657-3.00001-5
Yoshida, Y., Iriyama, T., Ariyoshi, Y., Yuji, I. D. A., Yano, E., Matsui, H., Suzuki, K., Hashimoto, A., Ichinose, M., Toshimitsu, M., et al. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-09306-8
“…increases in sFlt-1 levels due to subcutaneous LMWH and intravenous UFH, no data are available on the effects of subcutaneous UFH, another widely used prophylactic anticoagulant in pregnancy in instances of APS-related recurrent pregnancy loss or as bridging therapy near delivery [12, 25, 26].”
Townsend, J., & Attala, R. (2026) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2026.2700014
Ilgarovna, H. L., Sergeevna, S. A., Aleksandrovna, A. A., Andreevich, Y. N., Ivanovna, K. A., Sergeevna, B. E., Khoshimzhonovich, K. D., & Vladimirovich, P. B. (2025) · Journal of Neonatal Surgery
Treatment of Pregnancy Complications
Acaia, B., Rossi, F., & Chighizola, C. B. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_16
“2010 [ 16 ]).”
MethodResultInfluential
Metadata
- Authors
- Ziakas, P. D., Pavlou, M., & Voulgarelis, M.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Venue
- Obstetrics & Gynecology
- Published
- 2010-06
- Volume
- 115
- Issue
- 6
- Pages
- 1256-1262
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2083779542
- Cited by
- 185
- References
- 47
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 11 · 2022: 2 · 2021: 7 · 2020: 8 · 2019: 16 · 2018: 11 · 2017: 17 · 2016: 16 · 2015: 14 · 2014: 17 · 2013: 13 · 2012: 12
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- antiphospholipid syndrome, recurrent pregnancy loss, heparin, aspirin, low molecular weight heparin, unfractionated heparin, live birth rate, miscarriage prevention, combination anticoagulant therapy, pregnancy
- MeSH terms
- Abortion, Habitual, Aspirin, Drug Therapy, Combination, Female, Fibrinolytic Agents, Heparin, Humans, Pregnancy, Antiphospholipid Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.